We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shire | LSE:SHP | London | Ordinary Share | JE00B2QKY057 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4,690.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
12/4/2017 13:25 | Bought in today | jitters3 | |
02/3/2017 14:49 | We've definitely broken out of the downtrend on the chart now. We should make progress from here. | ygor706 | |
23/2/2017 17:42 | Chart looking good now with the downtrend broken tonight after a double bottom. | ygor706 | |
16/2/2017 13:44 | On a straight eps basis the 2016 results look disastrous ie down 81%. However, if you then look at the eps numbers for the fourth quarter of 2016 and multiply by four you come up with some very healthy prospective numbers for 2017. As with most pharma companies the numbers will need to be picked over by the experts but there looks to me to be a pretty good story here that is struggling to get out! | ygor706 | |
15/2/2017 22:25 | Watch Shire (SHP) closely on potential upcoming earnings-numbers surprise | arnu gutierrez | |
13/2/2017 18:23 | Results Thursday. | philo124 | |
13/2/2017 17:53 | Results out on Thursday I think. Should be an interesting week. | ygor706 | |
07/2/2017 13:30 | Nice move this morning. | philo124 | |
07/2/2017 13:07 | Shire's balance sheet positively sparkles in comparison with those of Astrazenca and GSK and its intangibles are also much smaller - although still sufficient to wipe out shareholders' funds. The latter shouldn't be an issue as long as trading and cash flow is on the front foot - which it is here. The cash balance was historically low at the end of 2015 but should pick up unless there has been a big spend on capital items. What strikes me is that the share price has basically been treading water for the past 2 1/2 years. A good set of numbers could nearly halve the PE and then I started to ask myself where Shire fits in with the other pharma big boys. I came up with the answer 'too cheap' but it's only a personal view and I'm in for the longer haul. | ygor706 | |
07/2/2017 10:48 | >>When you look at SHPG on Nasdaq it's still in a downtrend.>> Interesting. I'll check that out. >>They also have a huge amount of debt ...>> I thought they issued shares to buy Baltaxa. Will have to check that out as well. | zho | |
07/2/2017 10:21 | I'm slightly cautious about the chart - I think it may have bottomed because of the currency (GBPUSD rate). When you look at SHPG on Nasdaq it's still in a downtrend. They also have a huge amount of debt which has to be balanced with them looking cheap on earnings. I'm still watching them but I'm 50/50 on whether to buy or not. | jamielein | |
07/2/2017 09:51 | Looks v appealing on earnings grounds and the chart appears to have bottomed, but if pharmas come under pricing pressure from Trump then (expensive) rare disease treatments might fare poorly. | zho | |
25/1/2017 08:35 | Bought back in, looking for £48/50. | philo124 | |
08/12/2016 09:58 | Potential for decent spikes here, but chart is on a downward trendTrump tweets don't help | mbmiah | |
08/12/2016 09:20 | Trumpie has plans for profit gougers.. | bulltradept | |
07/12/2016 16:39 | Unencrypted Trump twitters make for feral equities. | steeplejack | |
07/12/2016 14:03 | Looking interesting again | mbmiah | |
03/12/2016 21:04 | Potential reaction of Shire (SHP) to analyst' perspective on its shares ( ) plus the topline data from VONVENDI trial ( ) | arnu gutierrez | |
10/11/2016 10:06 | Sold, £6 per share up minus costs. | philo124 | |
09/11/2016 09:25 | Got the timing right on the buy back at the mo. | philo124 | |
09/11/2016 08:51 | 20% upside now Obamacare is out of the way | bigboots | |
07/11/2016 12:19 | Bought back in this morning hoping to see £52 in due course. | philo124 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions